Valuation: Zenotech Laboratories Limited

Market Cap 2.35B 24.75M 22.17M 20.39M 18.48M 34.54M 35.18M 243M 97.62M 1.24B 92.89M 90.92M 3.9B P/E 2025
56.5x
P/E 2026 -191x
Enterprise Value 2.05B 21.55M 19.3M 17.75M 16.08M 30.07M 30.63M 212M 84.98M 1.08B 80.87M 79.15M 3.39B EV / Sales 2025
7.42x
EV / Sales 2026 4.45x
Free-Float
15.47%
Yield 2025 *
-
Yield 2026 -
Oct. 28 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2026 CI
Jul. 28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2026 CI
Apr. 29 Zenotech Laboratories Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2026 CI
Jan. 23 Zenotech Laboratories Limited Announces Cessation of Chintan Jitendra Shah as Independent Director, Chairman of the Nomination and Remuneration Committee, Member of Audit Committee/ Stakeholders Relationship Committee and Reconstitution of Board Committees CI
Jan. 23 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2025 CI
25-10-31 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2025 CI
25-09-25 Zenotech Laboratories Limited Announces Updation of Address of the Registered Office CI
25-07-28 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2025 CI
25-03-30 Zenotech Laboratories Limited Announces Cessation of Kavita Rakesh Shah as Independent Director, with Effect from April 01, 2025 CI
25-01-28 Zenotech Laboratories Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2024 CI
24-10-23 Zenotech Laboratories Limited Appoints Dr. Sachin Laxmanappa Gavandare as Chief Executive Officer (Key Managerial Personnel) CI
24-10-23 Zenotech Laboratories Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2024 CI
24-07-26 Zenotech Laboratories Limited Reports Earnings Results for the First Quarter Ended June 30, 2024 CI
1 day+1.48%
1 week-2.51%
Current month-7.94%
1 month-9.41%
3 months-13.25%
6 months-15.42%
Current year-16.63%
1 week 36.86
Extreme 36.86
39.8
1 month 36.86
Extreme 36.86
44.25
Current year 33.55
Extreme 33.55
50.93
1 year 33.55
Extreme 33.55
54.14
3 years 33.55
Extreme 33.55
107.79
5 years 33.55
Extreme 33.55
107.79
10 years 12
Extreme 12
107.79
Manager TitleAgeSince
Chief Executive Officer - 2024-10-22
Director of Finance/CFO - 2014-02-05
Chief Administrative Officer - -
Director TitleAgeSince
Director/Board Member 59 2015-07-07
Chairman 68 -
Director/Board Member 53 2020-01-31
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%-2.51%-26.51%-42.81% 24.32M
+3.03%+11.01%+67.40%+149.90% 1,224B
-0.63%+3.83%+44.88%+86.29% 662B
+1.25%+2.84%+28.73%+107.03% 514B
+0.42%+3.20%+54.15%+67.18% 388B
+2.32%+3.04%+73.48%+45.77% 361B
+1.12%+4.52%+35.30%+58.08% 302B
+6.96%+8.86%+11.27%+36.62% 271B
+1.21%+6.25%+59.83%+77.33% 249B
+2.92%+9.78%+44.63%+120.26% 205B
Average +2.08%+1.94%+39.32%+70.56% 417.69B
Weighted average by Cap. +2.01%+3.04%+50.83%+98.07%

Financials

2025 2026
Net sales 391M 4.12M 3.69M 3.39M 3.07M 5.75M 5.85M 40.45M 16.24M 206M 15.45M 15.12M 649M 402M 4.23M 3.79M 3.48M 3.16M 5.9M 6.01M 41.56M 16.68M 211M 15.87M 15.54M 666M
Net income 56.13M 591K 529K 487K 441K 825K 840K 5.81M 2.33M 29.53M 2.22M 2.17M 93.11M -10.72M -113K -101K -93.02K -84.28K -158K -160K -1.11M -445K -5.64M -424K -415K -17.79M
Net Debt -267M -2.81M -2.52M -2.32M -2.1M -3.92M -4M -27.63M -11.09M -140M -10.55M -10.33M -443M -304M -3.2M -2.87M -2.64M -2.39M -4.47M -4.55M -31.48M -12.64M -160M -12.03M -11.77M -505M
Projected Income Statement - Annual - Zenotech Laboratories Limited
Logo Zenotech Laboratories Limited
Zenotech Laboratories Limited is an India-based pharmaceutical company. The Company is engaged in a business of manufacture and marketing of pharmaceuticals products. The Company is a pharmaceutical specialty generic injectables company engaged in the area of manufacturing oncology, biotechnology and general injectables products. The Company’s injectables product portfolio primarily serves niche therapy areas like oncology and anesthesiology. Its product includes granulocyte-colony stimulating factor (GCSF) and Granulocyte-macrophage colony-stimulating factor (GMCSF). The Company has a manufacturing facility at Turkapally village, Shamirpet Mandal, Telangana.
Employees
264
Date Price Change Volume
26-10-30 ₹38.51 +1.48% 6,968
26-10-29 ₹37.95 +0.40% 19,861
26-10-28 ₹37.80 -1.84% 6,651
26-10-27 ₹38.51 -1.28% 6,109
26-10-26 ₹39.01 -3.23% 8,930
  1. Stock Market
  2. Stocks
  3. ZENOTECH6 Stock